GT Biopharma, Inc. (GTBP) announced it has regained compliance with The Nasdaq Stock Market's minimum bid price requirement of $1.00 per share, resolving a previously disclosed listing deficiency.
Key Details
- Compliance Confirmation: The company received a notice from Nasdaq on September 22, 2026, confirming it has satisfied the listing rule.
- Requirement Met: Compliance was achieved after the company's common stock maintained a closing bid price at or above $1.00 per share for at least 10 consecutive business days.
- Background: GTBP was initially notified of non-compliance on November 20, 2025, and was operating under a compliance period set to expire on November 16, 2026.